Primary outcome VO2 peak
| HIGH HOSP | LOW PED | Control | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | 6 weeks | 12 weeks | Baseline | 6 weeks | 12 weeks | Baseline | 6 weeks | 12 weeks | |
| Breast | n=11 | n=9 | n=9 | n=11 | n=9 | n=10 | n=11 | n=9 | n=10 |
| VO2 peak (L/min) | 1.8 (0.5) | 1.7 (0.5) | 1.6 (0.6)* | 1.8 (0.4) | 1.9 (0.4) | 1.6 (0.5)* | 2.1 (0.3) | 2.0 (0.3) | 1.9 (0.3)* |
| VO2 peak/BW (mL/min/kg) | 29.4 (9.0) | 29.4 (7.9) | 27.3 (7.7)* | 27.1 (6.4) | 26.8 (6.6) | 22.4 (6.5)* | 30.5 (5.0) | 28.8 (7.3) | 27.7 (6.8)* |
| Watt max (w) | 122 (52) | 134 (56) | 124 (53) | 135 (45) | 145 (43) | 126 (44) | 160 (30) | 157 (31) | 152 (29) |
| Colon | n=4 | n=3 | n=3 | n=3 | n=3 | n=2 | n=5 | n=2 | n=2 |
| VO2 peak (L/min) | 2.0 (0.4) | 2.3 (0.6) | 2.4 (0.6) | 1.9 (0.4) | 1.9 (0.4) | 2.2 (0.4) | 2.4 (1.0) | 2.7 (1.1) | 3.9 (0.5) |
| VO2 peak/BW (mL/min/kg) | 24.9 (2.8) | 26.4 (3.7) | 26.9 (4.6) | 27.4 (6.4) | 27.2 (5.7) | 31.0 (0.6) | 27.6 (10.2) | 31.6 (3.3) | 41.1 (10.0) |
| Watt max (W) | 148 (47) | 160 (43) | 170 (52) | 125 (51) | 138 (51) | 154 (44) | 200 (77) | 194 (92) | 289 (27) |
Data are presented as means and SD.
*Baseline versus 12 weeks: p<0.05.
BW, body weight; VO2 peak, peak oxygen consumption; Watt max, Watt power at the end of the incremental test.